Brevan Howard Capital Management’s Neurogene NGNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-8,064
Closed -$410K 1235
2024
Q1
$410K Buy
+8,064
New +$410K ﹤0.01% 477